Author Correction: The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.

Saved in:
Bibliographic Details
Title: Author Correction: The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.
Authors: Fidler TP; Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. Trevor.Fidler@ucsf.edu., Xue C; Cardiometabolic Precision Medicine Program, Cardiology Division, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.; Irving Institute for Clinical and Translational Research, Columbia University Irving Medical Center, New York, NY, USA., Yalcinkaya M; Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Hardaway B; Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Abramowicz S; Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Xiao T; Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Liu W; Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Thomas DG; Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Hajebrahimi MA; Medical Clinic I., Department of Cardiology, LMU Klinikum, Ludwig Maximilian University, Munich, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany., Pircher J; Medical Clinic I., Department of Cardiology, LMU Klinikum, Ludwig Maximilian University, Munich, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany., Silvestre-Roig C; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.; Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany., Kotini AG; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Luchsinger LL; Department of Medicine, Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY, USA., Wei Y; Columbia University, New York, NY, USA., Westerterp M; Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.; Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Snoeck HW; Department of Medicine, Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY, USA., Papapetrou EP; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Schulz C; Medical Clinic I., Department of Cardiology, LMU Klinikum, Ludwig Maximilian University, Munich, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany., Massberg S; Medical Clinic I., Department of Cardiology, LMU Klinikum, Ludwig Maximilian University, Munich, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany., Soehnlein O; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.; Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany.; Department of Physiology and Pharmacology (FyFa), Karolinska Institute, Stockholm, Sweden., Ebert B; Department of Medical Oncology, Dana-Faber Cancer Institute, Boston, MA, USA.; Howard Hughes Medical Institute, Dana-Faber Cancer Institute, Boston, MA, USA., Levine RL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reilly MP; Cardiometabolic Precision Medicine Program, Cardiology Division, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.; Irving Institute for Clinical and Translational Research, Columbia University Irving Medical Center, New York, NY, USA., Libby P; Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Wang N; Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. nw30@cumc.columbia.edu., Tall AR; Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. art1@cumc.columbia.edu.
Source: Nature [Nature] 2026 Jun; Vol. 654 (8117), pp. E8.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/s41586-026-10573-w